Textural Analysis as a Predictive Biomarker in Rectal Cancer
- PMID: 36620843
- PMCID: PMC9813797
- DOI: 10.7759/cureus.32241
Textural Analysis as a Predictive Biomarker in Rectal Cancer
Abstract
Colorectal cancer (CRC) is a common deadly cancer. Early detection and accurate staging of CRC enhance good prognosis and better treatment outcomes. Rectal cancer staging is the cornerstone for selecting the best treatment approach. The standard gold method for rectal cancer staging is pelvic MRI. After staging, combining surgery and chemoradiation is the standard management aiming for a curative outcome. Textural analysis (TA) is a radiomic process that quantifies lesions' heterogenicity by measuring pixel distribution in digital imaging. MRI textural analysis (MRTA) of rectal cancer images is growing in current literature as a future predictor of outcomes of rectal cancer management, such as pathological response to neoadjuvant chemoradiotherapy (NCRT), survival, and tumour recurrence. MRTA techniques could validate alternative approaches in rectal cancer treatment, such as the wait-and-watch (W&W) approach in pathologically complete responders (pCR) following NCRT. We consider this a significant step towards implementing precision management in rectal cancer. In this narrative review, we summarize the current knowledge regarding the potential role of TA in rectal cancer management in predicting the prognosis and clinical outcomes, as well as aim to delineate the challenges which obstruct the implementing of this new modality in clinical practice.
Keywords: : rectal cancer; imaging biomarker; life prognosis; recurrence predictors; textural analysis.
Copyright © 2022, Alrahawy et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Aker M, Boone D, Chandramohan A, Sizer B, Motson R, Arulampalam T. Abdom Radiol (NY) 2018;43:3213–3219. - PubMed
-
- Radiomics performs comparable to morphologic assessment by expert radiologists for prediction of response to neoadjuvant chemoradiotherapy on baseline staging MRI in rectal cancer. van Griethuysen JJ, Lambregts DM, Trebeschi S, et al. Abdom Radiol (NY) 2020;45:632–643. - PubMed
-
- AJCC 8th edition: colorectal cancer. Weiser MR. Ann Surg Oncol. 2018;25:1454–1455. - PubMed
Publication types
LinkOut - more resources
Full Text Sources